what might have been and still may be, page-8

I've found it strange since the beginning of the outbreak some 1 month ago that Biota hasn't used the opportunity to promote it's undervalued share price. PC even went on saying to journo's that speculators should be wary... or something along those lines. They did issue a slide show on their website though.

Why is this the case? It's almost like they have frozen commentary.

My guess (and it's a wild guess) is that they are in some sort of quiet time negotiating something which requires quiet time. License deal? I would have thought promoting yourself would be a good thing. Merger/takeover? Perhaps but once again isn't a higher share price a better option? Perhaps they have seen poor results elsewhere like the phase II HRV trial and are internally worried. Time will tell, I wish they just release HRV good or bad.